The personal and emotional elements of health care have long separated the industry from many of the forces that drive other forms of business. Unfortunately, those same elements have contributed, in part, to the unsustainable path our nation's health-care spending is on. However, in the following video, Brenton Flynn outlines one technology that, if used appropriately, could help patients immensely, while also making our health-care system more cost-efficient.
Want to know more about Abbott Labs?
For some Abbott Labs shareholders, the new year brought with it a new company called AbbVie. Formerly Abbott's branded pharmaceuticals business, shares of the new stock were distributed to investors on Jan. 2. To help investors better understand the situation, the Fool has created a brand new premium report on both stocks. Inside, we outline all of the must-know opportunities and risks facing both companies, so make sure to claim this report by clicking here now.
The article 1 Way Abbott Labs Can Fix Health Care originally appeared on Fool.com.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Genomic Health and Johnson & Johnson. The Motley Fool owns shares of Genomic Health and Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.